ABEO - Abeona Therapeutics Inc
IEX Last Trade
5.7
0.140 2.456%
Share volume: 179,968
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.56
0.14
2.52%
Summary score
6%
Profitability
0%
Dept financing
6%
Liquidity
46%
Performance
2%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.65%
Return on assets
-7.91%
Return on sales
0%
Return on invested capital
-45.34%
Total debt ratio
16.36%
Debt ratio change over timeo
-1.56%
Current Ratio
10.25%
Quick Ratio
0%
Cash Position Ratio
8.08%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.66%
Return on assets
-6.9%
Return on sales
0%
Return on invested capital
-98.49%
Total debt ratio
24.65%
Debt ratio change over timeo
-1.53%
Current Ratio
3.07%
Quick Ratio
0%
Cash Position Ratio
1.26%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-6.29%
Return on assets
-3.92%
Return on sales
0%
Return on invested capital
-45.04%
Total debt ratio
27.77%
Debt ratio change over time
-1.38%
Current Ratio
2.7%
Quick Ratio
0%
Cash Position Ratio
0.22%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-54.75%
Return on assets
-67.59%
Return on sales
0%
Return on invested capital
66.6%
Total debt ratio
-155.84%
Debt ratio change over time
-1.56%
Current Ratio
-55.3%
Quick Ratio
0%
Cash Position Ratio
-47.95%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABEO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.65% | -3.65% | 12.3% | 6.42% |
| Return on assets | -7.91% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | -45.34% | 4.99% | 7.81% | 13.62% |
| Profitability | 0% | 44% | 81% | 83% |
| Total debt ratio | 16.36% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -1.56% | 224.03% | 6.03% | 1.46% |
| Dept financing | 4% | 50% | 19% | 8% |
| Current Ratio | 3.07% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 1.26% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 16% | 35% | 37% |
| Short-term ratios | ABEO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15.66% | -16.17% | 18.05% | 7.63% |
| Return on assets | -6.9% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | -98.49% | 6.54% | 5.97% | 19.39% |
| Profitability | 0% | 43% | 75% | 85% |
| Total debt ratio | 24.65% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -1.53% | 851.68% | 10.97% | 0.58% |
| Dept financing | 6% | 50% | 21% | 8% |
| Current Ratio | 3.07% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 1.26% | 1.41% | 0.73% | 1.41% |
| Liquididy | 44% | 56% | 40% | 75% |